Catatan episode
Every month there's an avalanche of new research — but very little of it actually changes how we think about health.
In this episode of The Energy Code, Dr. Mike Belkowski breaks down the most important mitochondrial research published over the last month and separates genuine scientific progress from marketing hype.
You'll learn why independent testing revealed that some commercial red light therapy devices don't emit the wavelengths they claim, why that matters far more than advertised power output, and what consumers should actually be looking for.
Dr. Mike also explores the latest mechanistic research on methylene blue, the expanding clinical evidence behind Urolithin A, and a fascinating new body of mitochondrial science suggesting that dysfunctional mitochondria may actively drive inflammation and aging through cellular signaling — not simply by producing less energy.
If the recent science is pointing in one direction, it's this:
Mitochondrial quality may be one of the most important upstream regulators of health, resilience, and longevity.
Whether you're interested in red light therapy, methylene blue, Urolithin A, or simply understanding where longevity science is headed next, this episode provides an evidence-based review of the month's biggest developments.
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
"Wavelength is the identity of the treatment... Power output can often be compensated for. Wavelength cannot."
"Consumers should care whether companies are willing to have their products independently tested."
"Methylene blue is not a molecule where more automatically means better."
"Healthy mitochondria don't just make energy. They help determine how your cells respond to stress, inflammation, and aging."
"Every month, the science becomes a little clearer: mitochondrial health sits upstream of countless chronic diseases."
"The best longevity interventions don't replace biology — they help restore how biology was designed to function."
-
Key Points
⚡ Independent researchers tested commercial red light therapy devices with laboratory spectrometers and found that some failed to emit the wavelengths they claimed.
⚡ Wavelength accuracy may be more important than raw power output because wavelength determines the biological target being stimulated.
⚡ FDA Registered, FDA Cleared, and FDA Approved are very different regulatory classifications—and understanding the distinction matters.
⚡ The red light industry is beginning to mature, with manufacturers focusing more on wavelength selection and engineering than simply increasing wattage.
⚡ New mechanistic research continues strengthening our understanding of how methylene blue influences mitochondrial redox biology.
⚡ Methylene blue appears to provide its greatest mitochondrial benefits at lower doses, reinforcing its biphasic dose-response.
⚡ Safety remains paramount with methylene blue, particularly regarding serotonergic medications, dosing, and product purity.
⚡…
Situs: theenergycode.podbean.com

